A citation-based method for searching scientific literature

Ali Sakhdari, Beenu Thakral, Sanam Loghavi, Rashmi Kanagal-Shamanna, C Cameron Yin, Zhuang Zuo, Mark J Routbort, Rajyalakshmi Luthra, L Jeffrey Medeiros, Sa A Wang, Keyur P Patel, Chi Young Ok. Cancer Med 2020
Times Cited: 2







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.
Pieter Van Vlierberghe, Alberto Ambesi-Impiombato, Kim De Keersmaecker, Michael Hadler, Elisabeth Paietta, Martin S Tallman, Jacob M Rowe, Carles Forne, Montserrat Rue, Adolfo A Ferrando. Blood 2013
105
100

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Nitin Jain, Audrey V Lamb, Susan O'Brien, Farhad Ravandi, Marina Konopleva, Elias Jabbour, Zhuang Zuo, Jeffrey Jorgensen, Pei Lin, Sherry Pierce,[...]. Blood 2016
160
100

Management of adults with T-cell lymphoblastic leukemia.
David I Marks, Clare Rowntree. Blood 2017
79
100

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Amélie Trinquand, Aline Tanguy-Schmidt, Raouf Ben Abdelali, Jérôme Lambert, Kheira Beldjord, Etienne Lengliné, Noémie De Gunzburg, Dominique Payet-Bornet, Ludovic Lhermitte, Hossein Mossafa,[...]. J Clin Oncol 2013
154
100


Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.
Ching-Hon Pui, Jun J Yang, Stephen P Hunger, Rob Pieters, Martin Schrappe, Andrea Biondi, Ajay Vora, André Baruchel, Lewis B Silverman, Kjeld Schmiegelow,[...]. J Clin Oncol 2015
493
50

Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
P Van Vlierberghe, I Homminga, L Zuurbier, J Gladdines-Buijs, E R van Wering, M Horstmann, H B Beverloo, R Pieters, J P P Meijerink. Leukemia 2008
18
50

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.
María-Belén Vidriales, José J Pérez, Maria Consuelo López-Berges, Norma Gutiérrez, Juana Ciudad, Paulo Lucio, Lourdes Vazquez, Ramón García-Sanz, Maria Consuelo del Cañizo, Javier Fernández-Calvo,[...]. Blood 2003
99
50

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Jacob M Rowe, Georgina Buck, Alan K Burnett, Raj Chopra, Peter H Wiernik, Susan M Richards, Hillard M Lazarus, Ian M Franklin, Mark R Litzow, Niculae Ciobanu,[...]. Blood 2005
463
50

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study.
Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Sebastian Giebel, Krystyna Jagoda, Beata Stella-Holowiecka, Beata Piatkowska-Jakubas, Monika Paluszewska, Ilona Seferynska, Krzysztof Lewandowski, Marek Kielbinski,[...]. Br J Haematol 2008
94
50

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.
Arnaud Petit, Amélie Trinquand, Sylvie Chevret, Paola Ballerini, Jean-Michel Cayuela, Nathalie Grardel, Aurore Touzart, Benoit Brethon, Hélène Lapillonne, Claudine Schmitt,[...]. Blood 2018
55
50

The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.
Obul R Bandapalli, Stephanie Schuessele, Joachim B Kunz, Tobias Rausch, Adrian M Stütz, Noa Tal, Ifat Geron, Nava Gershman, Shai Izraeli, Juliane Eilers,[...]. Haematologica 2014
81
50

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
M Kawamura, H Ohnishi, S X Guo, X M Sheng, M Minegishi, R Hanada, K Horibe, T Hongo, Y Kaneko, F Bessho,[...]. Leuk Res 1999
87
50

High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A Moreau, Stuart S Winter,[...]. Blood 2009
321
50

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.
Graça M Dores, Susan S Devesa, Rochelle E Curtis, Martha S Linet, Lindsay M Morton. Blood 2012
375
50

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
Monika Brüggemann, Thorsten Raff, Thomas Flohr, Nicola Gökbuget, Makoto Nakao, Jo Droese, Silke Lüschen, Christiane Pott, Matthias Ritgen, Urban Scheuring,[...]. Blood 2006
368
50

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Silvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta, Pamela Zanghi, Elena Oldani, Cristina Boschini, Alexander Kohlmann, Silvia Bungaro,[...]. Haematologica 2016
19
50

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
Jennifer O'Neil, Jonathan Grim, Peter Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James Hardwick, Markus Welcker, Jules P Meijerink, Rob Pieters,[...]. J Exp Med 2007
504
50

NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.
Patrick A Brown, Bijal Shah, Amir Fathi, Matthew Wieduwilt, Anjali Advani, Patricia Aoun, Stefan K Barta, Michael W Boyer, Teresa Bryan, Patrick W Burke,[...]. J Natl Compr Canc Netw 2017
48
50

Molecular pathogenesis of T-cell leukaemia and lymphoma.
Iannis Aifantis, Elizabeth Raetz, Silvia Buonamici. Nat Rev Immunol 2008
299
50

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia.
Chi Young Ok, Sanam Loghavi, Dawen Sui, Peng Wei, Rashmi Kanagal-Shamanna, C Cameron Yin, Zhuang Zuo, Mark J Routbort, Guilin Tang, Zhenya Tang,[...]. Haematologica 2019
35
50

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
S Jenkinson, K Koo, M R Mansour, N Goulden, A Vora, C Mitchell, R Wade, S Richards, J Hancock, A V Moorman,[...]. Leukemia 2013
55
50

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Jinghui Zhang, Li Ding, Linda Holmfeldt, Gang Wu, Sue L Heatley, Debbie Payne-Turner, John Easton, Xiang Chen, Jianmin Wang, Michael Rusch,[...]. Nature 2012
50

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Teresa Palomero, Maria Luisa Sulis, Maria Cortina, Pedro J Real, Kelly Barnes, Maria Ciofani, Esther Caparros, Jean Buteau, Kristy Brown, Sherrie L Perkins,[...]. Nat Med 2007
668
50

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Josep-María Ribera, Albert Oriol, Miguel-Angel Sanz, Mar Tormo, Pascual Fernández-Abellán, Eloy del Potro, Eugenia Abella, Javier Bueno, Ricardo Parody, Pilar Bastida,[...]. J Clin Oncol 2008
187
50

Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
L Gallo Llorente, H Luther, R Schneppenheim, M Zimmermann, M Felice, M A Horstmann. Pediatr Blood Cancer 2014
9
50

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
50

NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Yong-Mei Zhu, Wei-Li Zhao, Jian-Fei Fu, Jing-Yi Shi, Qin Pan, Jiong Hu, Xiao-Dong Gao, Bing Chen, Jun-Min Li, Shu-Min Xiong,[...]. Clin Cancer Res 2006
113
50


A novel four-color PCR assay to assess T-cell receptor gamma gene rearrangements in lymphoproliferative lesions.
F Vega, L J Medeiros, D Jones, L V Abruzzo, R Lai, J Manning, V Dunmire, R Luthra. Am J Clin Pathol 2001
71
50

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
David I Marks, Elisabeth M Paietta, Anthony V Moorman, Susan M Richards, Georgina Buck, Gordon DeWald, Adolfo Ferrando, Adele K Fielding, Anthony H Goldstone, Rhett P Ketterling,[...]. Blood 2009
233
50

The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
C Kox, M Zimmermann, M Stanulla, S Leible, M Schrappe, W-D Ludwig, R Koehler, G Tolle, O R Bandapalli, S Breit,[...]. Leukemia 2010
98
50

HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation.
J Bergeron, E Clappier, B Cauwelier, N Dastugue, C Millien, E Delabesse, K Beldjord, F Speleman, J Soulier, E Macintyre,[...]. Leukemia 2006
22
50

HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?
Jules Pp Meijerink, Kirsten Canté-Barrett, Eric Vroegindeweij, Rob Pieters. Haematologica 2016
4
50

TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
Sabina Chiaretti, Fulvia Brugnoletti, Simona Tavolaro, Silvia Bonina, Francesca Paoloni, Marilisa Marinelli, Nancy Patten, Massimiliano Bonifacio, Maria Grazia Kropp, Simona Sica,[...]. Haematologica 2013
44
50

Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Claudia D Baldus, Julia Thibaut, Nicola Goekbuget, Andrea Stroux, Cornelia Schlee, Max Mossner, Thomas Burmeister, Stefan Schwartz, Clara D Bloomfield, Dieter Hoelzer,[...]. Haematologica 2009
55
50

The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia.
David J Curtis, Matthew P McCormack. Clin Cancer Res 2010
30
50

The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
Vera Grossmann, Claudia Haferlach, Sandra Weissmann, Andreas Roller, Sonja Schindela, Franziska Poetzinger, Kathrin Stadler, Frauke Bellos, Wolfgang Kern, Torsten Haferlach,[...]. Genes Chromosomes Cancer 2013
112
50

TLX1-induced T-cell acute lymphoblastic leukemia.
Kim De Keersmaecker, Adolfo A Ferrando. Clin Cancer Res 2011
13
50

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
Johan T den Dunnen, Raymond Dalgleish, Donna R Maglott, Reece K Hart, Marc S Greenblatt, Jean McGowan-Jordan, Anne-Francoise Roux, Timothy Smith, Stylianos E Antonarakis, Peter E M Taschner. Hum Mutat 2016
768
50


Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.
Kheira Beldjord, Sylvie Chevret, Vahid Asnafi, Françoise Huguet, Marie-Laure Boulland, Thibaut Leguay, Xavier Thomas, Jean-Michel Cayuela, Nathalie Grardel, Yves Chalandon,[...]. Blood 2014
200
50

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, Frédéric Baleydier, Arnauld Simon, Kheira Beldjord, Oumedaly Reman, Francis Witz, Thierry Fagot, Emmanuelle Tavernier,[...]. Blood 2009
151
50

Integrative genomics viewer.
James T Robinson, Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S Lander, Gad Getz, Jill P Mesirov. Nat Biotechnol 2011
50

NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
L Zuurbier, I Homminga, V Calvert, M L te Winkel, J G C A M Buijs-Gladdines, C Kooi, W K Smits, E Sonneveld, A J P Veerman, W A Kamps,[...]. Leukemia 2010
101
50

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.
Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Yuanyuan Zhu, Xiujin Ye,[...]. Blood 2014
124
50

Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
Eulàlia Genescà, Mireia Morgades, Pau Montesinos, Pere Barba, Cristina Gil, Ramon Guàrdia, María-José Moreno, Daniel Martínez-Carballeira, Irene García-Cadenas, Susana Vives,[...]. Haematologica 2020
17
50


p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia.
Jean Hughes Dalle, Martine Fournier, Brigitte Nelken, Françoise Mazingue, Jean-Luc Laï, Francis Bauters, Pierre Fenaux, Bruno Quesnel. Blood 2002
24
50

Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
Manisha Agarwal, Sameer Bakhshi, Sadanand N Dwivedi, Madhulika Kabra, Rashmi Shukla, Rachna Seth. Pediatr Blood Cancer 2018
11
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.